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Serum uric acid has been shown to be associated with cardiovascular disease, hypertension, and chronic kidney disease in previous
studies. However, few studies have examined the association between serum uric acid and diabetes mellitus and their findings
are not consistent. Therefore, we examined the association between serum uric acid levels and diabetes mellitus in participants
from the third National Health and Nutrition Examination Survey (n = 18, 825, 52.5% women). Serum uric acid levels were
categorized into quartiles. Diabetes mellitus was defined as fasting glucose ≥126 mg/dL, nonfasting glucose ≥200 mg/dL, or use of
oral hypoglycemic medication or insulin (n = 395). In multivariable logistic regression models, we found that higher serum uric
acid levels were inversely associated with diabetes mellitus after adjusting for age, sex, race/ethnicity, education, smoking, alcohol
intake, body mass index, hypertension, and serum cholesterol. Compared to quartile 1 of serum uric acid, the odds ratio (95%
confidence interval) of diabetes mellitus was 0.48 (0.35–0.66; P trend < 0.0001). The results were consistent in subgroup analysis
by gender and hypertension status. Higher serum uric acid levels were inversely associated with diabetes mellitus in a representative
sample of US adults.

1. Introduction

2. Methods

Serum uric acid, an end product of purine metabolism,
has been shown to be associated with an increased risk of
hypertension [1–3], cardiovascular disease [2, 4], and chronic kidney disease [5] in previous epidemiological studies.
Also, elevated levels of uric acid is a risk factor for peripheral
arterial disease [6], insulin resistance, and components of the
metabolic syndrome [7]. However, the putative association
between serum uric acid levels and diabetes mellitus is not
clear. Some studies reported that there is a positive association between high serum uric acid levels and diabetes [8–13],
whereas other studies reported no association [14], or an
inverse relationship [15, 16]. In this context, the main
purpose of our study was to examine the association between
serum uric acid and prevalent diabetes in a large nationally
representative sample of US adults after adjusting for major
confounders. We had adequate sample size to examine this
association in the whole cohort as well as separately by
gender and hypertension.

The current study is based on data from the third National
Health and Nutrition Examination Survey (NHANES III).
Detailed description of NHANES III study design and
methods are available elsewhere [17–20]. In brief, the
NHANES survey included a stratified multistage probability
sample representative of the civilian noninstitutionalized
US population. Selection was based on counties, blocks,
households, and individuals within households, and it
included the oversampling of non-Hispanic blacks and
Mexican Americans in order to provide stable estimates of
these groups. Subjects were required to sign a consent form
before their participation, and approval was obtained from
the Human Subjects Committee in the US Department of
Health and Human Service.
The current study sample consisted of participants aged
greater than 20 years who were randomly assigned to be
examined in the morning exam after an overnight fast.
Serum uric acid levels were measured in 17,008 participants
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who were examined in the morning after an overnight
fast who had surplus sera available. We further excluded
subjects with self-reported cardiovascular disease (n =
1, 521) and also subjects with missing data (n = 1, 343)
on covariates included in the multivariable model, including
systolic or diastolic blood pressure, body mass index (BMI),
or cholesterol levels. This resulted in 14,144 participants
(52.5% women), 1,021 of whom had diabetes mellitus.

3. Main Outcome of Interest
Serum glucose was measured using the modified hexokinase
method at the University of Missouri, Diabetes Diagnostic
Laboratory. Diabetes was defined based on the guidelines
of the American Diabetes Association as a serum glucose
≥126 mg/dL after fasting for a minimum of 8 hours, a serum
glucose ≥200 mg/dL for those who fasted <8 hours before
their NHANES visit, or a self-reported current use of oral
hypoglycemic medication or insulin.

4. Exposure Measurements
Age, gender, race/ethnicity, smoking status, alcohol intake
(g/day), level of education, history of diabetes and oral hypoglycemic intake or insulin administration, and antihypertensive medication use were assessed using a questionnaire.
Individuals who had not smoked ≥100 cigarettes in their
lifetimes were considered never smokers; those who had
smoked ≥100 cigarettes in their lifetimes were considered
former smokers if they answered negatively to the question
“Do you smoke now?” and current smokers if they answered
aﬃrmatively. Body mass index (BMI) was calculated as
weight in kilograms divided by height in meters squared.
Serum total cholesterol was measured enzymatically.
Rigorous procedures with quality control checks were
used in blood collection, and details about these procedures are provided in the NHANES Laboratory/Medical
Technologists Procedures Manual [18–20]. Measurement of
serum uric acid was performed by Collaborative Laboratory
Services at Ottumwa, Iowa, using Beckman Synchron LX20
method. The LX20 uses a timed endpoint method to measure
the concentration of uric acid in serum. Uric acid is oxidized
by uricase to produce allantoin and hydrogen peroxide. The
hydrogen peroxide reacts with 4-aminoantipyrine (4-AAP)
and 3,5-dichloro-2-hydroxybenzene sulfonate (DCHBS) in
a reaction catalyzed by peroxidase to produce a colored
product. The system monitors the change in absorbance at
520 nm at a fixed time interval. The change in absorbance is
directly proportional to the concentration of uric acid in the
sample.

5. Statistical Analysis
Serum uric acid was analyzed as a categorical variable. We
categorized serum uric acid level as quartiles (<4.3 mg/dL,
4.30–5.20 mg/dL, 5.30–6.20 mg/dL, >6.20 mg/dL).
The odds ratio [(OR) (95% confidence interval (CI)]
of diabetes mellitus for each higher uric acid quartile was
calculated by taking the lowest quartile as the referent,
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using multivariable logistic regression models. We used two
models: the age- and sex-adjusted model, and the multivariable model, additionally adjusting for race/ethnicity (nonHispanic whites, non-Hispanic blacks, Mexican Americans,
etc.), education categories (below high school, high school,
above high school), smoking (never smoker, former smoker,
current smoker), alcohol intake (g/day), BMI (normal,
overweight, obese), hypertension (absent, present), and total
serum cholesterol (mg/dL). Trends in the OR of diabetes
mellitus across increasing serum uric acid category were
determined by modeling uric acid categories as an ordinal
variable. Sample weights that account for the unequal probabilities of selection, oversampling, and nonresponse were
applied for all analyses using SUDAAN (version 8.0; Research
Triangle Institute, Research Triangle Park, NC, USA) and
SAS (version 9.2; SAS Institute, Cary, NC, USA) software;
SEs were estimated using the Taylor series linearization
method. To examine the dose-response relationship between
the observed association between serum uric acid levels and
diabetes mellitus without linearity assumptions, we used
flexible nonparametric logistic regression employing the
generalized additive modeling approach (R system for statistical computing, available from Comprehensive R Archive
Network (http://www.CRAN.R-project.org/)) and calculated
the odds of diabetes mellitus, adjusting for all covariates in
the multivariable model. The odds of diabetes mellitus were
then plotted against increasing serum uric acid levels (both
on the log scale) [21].

6. Results
Table 1 presents the baseline characteristics of the study
population by increasing quartiles of serum uric acid level.
Individuals in the higher uric acid quartiles were more likely
to be older, non-Hispanic blacks, overweight and obese and
have high total cholesterol levels.
Table 2 presents the association between increasing
serum uric acid levels and diabetes mellitus in the whole
cohort. We observed an inverse association between serum
uric acid levels and diabetes mellitus in both the agesex-adjusted and the multivariable-adjusted models. In a
supplementary analysis where we examined the association
between uric acid and diabetes mellitus defined in addition
to fasting glucose as raised HbA1C (levels > 6.5%), compared
to quartile 1 (referent) the multivariable adjusted odds ratio
(95% CI) of diabetes in quartile 2 was 0.61 (0.42–0.89),
quartile 3 was 0.50 (0.38–0.65), and in quartile 4 was 0.61
(0.45–0.83); P trend = 0.004.
In Table 3, the inverse association between increasing
serum uric acid levels and diabetes mellitus was consistently
present among men and women; however, the association
was stronger in men. Table 4 presents the association
between increasing serum uric acid levels and diabetes mellitus by hypertension status. Consistent with the findings in
Table 2 there was an inverse relationship between increasing
serum uric acid levels and diabetes mellitus in nonhypertensive subjects and hypertensive subjects in multivariableadjusted model. We then employed nonparametric models to
examine if the observed inverse association between serum
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Table 1: Characteristics of the study population by categories of serum uric acid level∗† .
Characteristics
Age, years
Women, %
Race-ethnicity, %
Non-Hispanic whites
Non-Hispanic blacks
Mexican Americans
Others
Education categories, %
Below high school
High school
Above high school
Smoking, %
Never smoker
Former smoker
Current smoker
Alcohol intake, %
Current drinker
Body mass index, kg/m2
Normal
Overweight
Obese
Total cholesterol, mg/dL
∗

Quartile 1
43.91 ± 0.31
53.52 ± 1.57

Quartile 2
43.66 ± 0.31
55.77 ± 1.18

Quartile 3
46.58 ± 0.31
49.49 ± 1.26

Quartile 4
50.71 ± 0.31
51.01 ± 1.12

77.75 ± 1.65
9.73 ± 0.67
5.60 ± 0.49
6.92 ± 1.17

78.17 ± 1.45
9.84 ± 0.65
5.17 ± 0.42
6.82 ± 1.04

75.53 ± 1.43
9.71 ± 0.73
5.32 ± 0.58
9.44 ± 1.15

75.59 ± 1.53
12.45 ± 0.88
4.62 ± 0.42
7.35 ± 0.89

22.36 ± 1.40
32.19 ± 1.35
45.45 ± 2.11

21.59 ± 1.14
35.88 ± 1.19
42.53 ± 1.63

22.71 ± 1.33
33.47 ± 1.52
43.82 ± 1.66

27.19 ± 1.35
34.56 ± 0.99
38.25 ± 1.38

49.08 ± 1.45
20.21 ± 1.07
30.72 ± 1.21

46.21 ± 1.52
22.78 ± 1.02
31.01 ± 1.62

50.17 ± 1.64
23.91 ± 1.19
25.92 ± 1.33

47.05 ± 1.31
28.22 ± 0.98
24.74 ± 1.18

54.36 ± 1.99

55.17 ± 1.80

57.91 ± 1.45

53.44 ± 1.81

63.90 ± 1.40
26.95 ± 1.10
9.16 ± 0.77
195.03 ± 0.73

53.22 ± 1.14
32.28 ± 0.89
14.50 ± 0.98
200.54 ± 0.72

38.79 ± 1.28
36.33 ± 1.44
24.88 ± 1.11
207.12 ± 0.73

24.36 ± 0.88
35.97 ± 1.31
39.67 ± 1.22
214.81 ± 0.73

P value
<0.0001
0.0073
0.0010

0.0002

<0.0001

0.0680
<0.0001

<0.0001

Data presented are row percentages or mean values ± standard error (SE).
uric acid quartiles: <4.3 mg/dL, 4.30–5.20 mg/dL, 5.30–6.20 mg/dL, >6.20 mg/dL.

† Serum

Table 2: Association between serum uric acid level and diabetes mellitus.
Serum uric acid level∗
Quartile 1 (<4.30 mg/dL)
Quartile 2
(4.30–5.20 mg/dL)
Quartile 3
(5.30–6.20 mg/dL)
Quartile 4 (>6.20 mg/dL)
P trend

Number at risk
(Diabetes cases)
3482 (305)

Age- and sex-adjusted odds ratio
(95% confidence interval)
1 (referent)

Multivariable-adjusted odds ratio
(95% confidence interval)†
1 (referent)

3624 (206)

0.63 (0.44–0.91)

0.54 (0.36–0.80)

3499 (185)

0.62 (0.45–0.85)

0.40 (0.29–0.56)

3539 (325)

0.54 (0.30–097)
0.0023

0.48 (0.35–0.66)
<0.0001

∗

Serum uric acid quartiles: <4.3 mg/dL, 4.30–5.20 mg/dL, 5.30–6.20 mg/dL, >6.20 mg/dL.
for age (years), sex (men, women), race-ethnicity (non-Hispanic whites, non-Hispanic blacks, Mexican Americans, etc.), education categories
(<high school, high school, >high school), smoking (never, former, current), alcohol intake (never, former, current), BMI (normal, overweight, obese),
hypertension (absent, present), and serum total cholesterol (mg/dL).

† Adjusted

uric acid and diabetes mellitus was present across the full
range of serum uric acid levels available in the present study
(Figure 1). Overall, there appeared to be a continuous inverse
association between serum uric acid and diabetes mellitus
with increasing serum uric acid levels; there is no evidence
of any threshold eﬀect.

7. Discussion
Higher serum uric acid levels were found to be inversely
associated with diabetes mellitus in a large, contemporary,

multiethnic sample of US adults. The observed inverse
relation between serum uric acid and diabetes mellitus
appeared to be independent of potential confounders and
was consistently present in subgroup analyses by gender
and hypertension. In a subsequent analysis, employing
nonparametric models, the observed inverse association
between serum uric acid quartiles and diabetes mellitus was
present continuously across the full range of serum uric
acid.
Previous studies examining the association between
serum uric acid levels and diabetes mellitus were restricted
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Table 3: Association between serum uric acid level and diabetes
mellitus by gender.
Serum uric acid
level∗
Women
Quartile 1
(<3.8 mg/dL)
Quartile 2
(3.8–4.5 mg/dL)
Quartile 3
(4.6–5.4 mg/dL)
Quartile 4
(>5.4 mg/dL)
P trend
Men
Quartile 1
(<5.20 mg/dL)
Quartile 2
(5.20–5.9 mg/dL)
Quartile 3
(6.0–6.8 mg/dL)
Quartile 4
(>6.8 mg/dL)
P trend

Number at risk
(Diabetes cases)

Multivariable-adjusted
odds ratio (95%
confidence interval)†

1839 (113)

1 (referent)

2046 (121)

0.79 (0.49–1.28)

1843 (103)

0.53 (0.33–0.83)

1881 (209)

0.78 (0.51–1.20)
0.3590

1643 (192)

1 (referent)

1578 (85)

0.42 (0.23–0.76)

1656 (82)

0.35 (0.21–0.58)

1658 (116)

0.32 (0.20–0.51)
<0.0001

Table 4: Association between serum uric acid level and diabetes
mellitus by hypertension.
Serum uric acid
level∗
No hypertension
Quartile 1
(<4.30 mg/dL)
Quartile 2
(4.30–5.20 mg/dL)
Quartile 3
(5.30–6.20 mg/dL)
Quartile 4
(>6.20 mg/dL)
P trend
Hypertension
Quartile 1
(<4.30 mg/dL)
Quartile 2
(4.30–5.20 mg/dL)
Quartile 3
(5.30–6.20 mg/dL)
Quartile 4
(>6.20 mg/dL)
P trend

Number at risk
(Diabetes cases)

Multivariable-adjusted
odds ratio (95%
confidence interval)†

2623 (150)

1 (referent)

2651 (89)

0.45 (0.25–0.80)

2271 (54)

0.29 (0.16–0.54)

1721 (77)

0.40 (0.22–0.70)
0.0015

859 (155)

1 (referent)

973 (117)

0.66 (0.43–1.01)

1228 (131)

0.52 (0.35–0.76)

1818 (248)

0.57 (0.38–0.86)
0.0232

∗

Serum uric acid quartiles: <4.3 mg/dL, 4.30–5.20 mg/dL, 5.30–6.20 mg/dL,
>6.20 mg/dL.
† Adjusted for age (years), race-ethnicity (non-Hispanic whites, nonHispanic blacks, Mexican Americans, etc.), education categories (<high
school, high school, >high school), smoking (never, former, current),
alcohol intake (never, former, current), BMI (normal, overweight, obese),
hypertension (absent, present), and serum total cholesterol (mg/dL).

∗

to specific racial/ethnic groups and gender and were not
consistent in their findings. Some studies reported that there
is a positive association between elevated serum uric acid levels and diabetes [8–13], whereas some other study reported
no positive association between serum uric acid and diabetes
mellitus [14]. Also, some studies reported that serum uric
acid is inversely associated with diabetes mellitus [15, 16].
The exact reason for why previous studies found a positive
relation between uric acid and diabetes is not clear. Most of
these studies were limited by small sample sizes, including
either men or women and not both, not having data on
confounding factors, or were from selected populations
such as industrial workers as opposed to general population
samples.
A plausible mechanism for the observed results of an
inverse association between increasing serum uric acid and
diabetes mellitus may be related to the inhibition of uric acid
reabsorption in the proximal tubule by high glucose levels
in diabetic individuals [22, 23]. To clarify the independent
relation between serum uric acid levels and diabetes mellitus,
we decided to adjust for all potential confounders and do
subgroup analysis by gender. We found that in the current
study, an inverse association was observed between elevated
serum uric acid and diabetes mellitus even after adjusting for
age, sex, race-ethnicity, education, smoking, alcohol intake,

BMI, hypertension, and serum total cholesterol in both
subgroup analysis by gender and hypertension. The large
sample size available for the current analyses, our ability
to adjust for all potential confounders, and the consistency
of these results after subgroup analysis by gender and
hypertension suggests that our findings are less likely due to
chance. Therefore, higher uric acid levels may not be a risk
factor for diabetes mellitus as some researchers previously
argued [8–13].
The main strengths of our study include its populationbased nature, inclusion of a representative multiethnic sample, and the availability of data on confounders for multivariable adjustment. We had a large sample size that enabled us
to perform separate analysis by gender. Furthermore, all data
were collected following rigorous methodology, including a
study protocol with standardized quality control checks. The
main limitation of our study is the cross-sectional nature
of NHANES, which precludes conclusions regarding the
temporal nature of the association between serum uric acid
levels and diabetes mellitus. Therefore, even though we are
able to detect an association that is statistically independent
of traditional confounding factors such as age, BMI, and
serum cholesterol, we are not able to establish which one
is the cause and which the is an eﬀect. Prospective studies
are needed to establish the time sequence in the relationship

Serum uric acid quartiles: <4.3 mg/dL, 4.30–5.20 mg/dL, 5.30–6.20 mg/dL,
>6.20 mg/dL.
† Adjusted for age (years), sex (men, women), race-ethnicity (non-Hispanic
whites, non-Hispanic blacks, Mexican Americans, etc.), education categories
(<high school, high school, >high school), smoking (never, former,
current), alcohol intake (never, former, current), BMI (normal, overweight,
obese), and serum total cholesterol (mg/dL).
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Figure 1: Multivariable-adjusted odds of diabetes mellitus according to serum uric acid level. Solid thick line represents the predicted
odds of diabetes estimated from nonparametric logistic regression
employing the generalized addictive-modeling approach (R system
for statistical computing, Comprehensive R Archive Network
(http://www.CRAN.R-project.org/)); dashed lines, 95% confidence
limits for the nonparametric logistic regression estimates. The
nonparametric logistic regression was adjusted for age (years),
sex (men, women), race-ethnicity (non-Hispanic whites, nonHispanic blacks, Mexican Americans, etc.), education categories
(<high school, high school, >high school), smoking (never, former,
current), alcohol intake (never, former, current), BMI (normal,
overweight, obese), and serum total cholesterol (mg/dL). x axis:
serum uric acid level (mg/dL) plotted in log scale, y1 axis:
predicted odds of diabetes mellitus plotted in log scale, and y2 axis:
participant number for each serum uric acid level.

between uric acid and diabetes mellitus. In summary, in a
multiethnic sample of US adults, we found that higher serum
uric acid levels are inversely associated with diabetes mellitus
in both men and women.
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